Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

被引：1

作者：

Rodvold, Keith A. ^{[1
]}

机构：

[1] Univ Illinois, Coll Pharm & Med, Chicago, IL 60612 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2015年 / 61卷

关键词：

telavancin; lipoglycopeptide; methicillin-resistant Staphylococcus aureus; skin infections; pneumonia; BROTH MICRODILUTION METHOD; GRAM-POSITIVE BACTERIA; SOFT-TISSUE INFECTIONS; COMPLICATED SKIN; STANDARD THERAPY; VANCOMYCIN; PNEUMONIA;

D O I：

10.1093/cid/civ524

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S35 / S37

页数：3

共 18 条

[1] Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment [J].

Cardona, Amilcar F. ;

Wilson, Samuel E. .

CLINICAL INFECTIOUS DISEASES, 2015, 61 :S69-S78

[2]

Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC

[3] Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival [J].

Corey, G. Ralph ;

Kollef, Marin H. ;

Shorr, Andrew F. ;

Rubinstein, Ethan ;

Stryjewski, Martin E. ;

Hopkins, Alan ;

Barriere, Steven L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :2030-2037

[4] Revised Reference Broth Microdilution Method for Testing Telavancin: Effect on MIC Results and Correlation with Other Testing Methodologies [J].

Farrell, David J. ;

Mendes, Rodrigo E. ;

Rhomberg, Paul R. ;

Jones, Ronald N. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :5547-5551

[5] Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance [J].

Karlowsky, James A. ;

Nichol, Kim ;

Zhanel, George G. .

CLINICAL INFECTIOUS DISEASES, 2015, 61 :S58-S68

[6] Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality [J].

Lacy, Melinda K. ;

Stryjewski, Martin E. ;

Wang, Whedy ;

Hardin, Thomas C. ;

Nogid, Boris ;

Luke, David R. ;

Shorr, Andrew F. ;

Corey, G. Ralph ;

Barriere, Steven L. .

CLINICAL INFECTIOUS DISEASES, 2015, 61 :S87-S93

[7] MRSA: the first half century [J].

Moellering, Robert C., Jr. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) :4-11

[8] Evolving Resistance Among Gram-positive Pathogens [J].

Munita, Jose M. ;

Bayer, Arnold S. ;

Arias, Cesar A. .

CLINICAL INFECTIOUS DISEASES, 2015, 61 :S48-S57

[9] Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future [J].

Rodvold, Keith A. ;

McConeghy, Kevin W. .

CLINICAL INFECTIOUS DISEASES, 2014, 58 :S20-S27

[10] Quality Control MIC Ranges Used for Telavancin with Application of a Revised CLSI Reference Broth Microdilution Method [J].

Ross, James E. ;

Mendes, Rodrigo E. ;

Jones, Ronald N. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (09) :3399-3401

← 1 2 →